Form 4: Cardinal Health Director Receives RSU Grant

Cardinal Health Director David C. Evans was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Director David C. Evans of Cardinal Health Inc. (CAH) received a grant of 1,067 common shares in the form of restricted share units (RSUs).
• The transaction occurred on November 5, 2025.
• The RSUs were granted at a price of $0, indicating they are part of a compensation package.
• Following this transaction, David C. Evans beneficially owns 15,373 common shares directly.
• These restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders takes place before that date.
• A Limited Power of Attorney, dated May 5, 2025, authorizes several individuals, including James E. Barnett (who signed the Form 4), to file SEC reports on behalf of David C. Evans.

Sentiment

Score: 7

Explanation: The filing reports a standard equity grant to a director, which is generally a positive sign of aligning interests, but it's a routine disclosure with no significant new operational or financial news.

Positives

• The grant of 1,067 restricted share units to Director David C. Evans aligns his interests with long-term shareholder value.
• The vesting schedule, tied to either a specific date or the 2026 Annual Meeting, provides a clear incentive for continued performance.

Negatives

• No explicit negatives are present in this Form 4 filing, which primarily reports an insider transaction.

Risks

• The value of the restricted share units is subject to the future performance of Cardinal Health Inc.'s common shares.
• The vesting of the RSUs is contingent on continued service as a director until the vesting date.

Future Outlook

The filing indicates a future vesting event for the granted restricted share units on November 5, 2026, or potentially earlier, aligning director incentives with future company performance.

Industry Context

This is a routine insider transaction filing reporting an equity grant to a director. Such grants are common practice in publicly traded companies to align executive and director interests with shareholder value, particularly in the healthcare distribution and services industry where Cardinal Health operates.

Comparison to Industry Standards

• Equity grants to directors, such as restricted share units, are a standard component of compensation packages across the healthcare and pharmaceutical distribution industry, including peers like McKesson Corporation and AmerisourceBergen Corporation.
• The vesting schedule, typically over one to three years, is also consistent with industry norms designed to promote long-term commitment and performance.
• The grant of 1,067 RSUs is a specific amount for this individual director and would need to be compared to similar grants at comparable companies to assess its relative size, but the mechanism itself is standard.

Corporate Governance

Related Party Transactions

• The RSU grant is a transaction between the company and a director, which is a related party, but it is a standard compensation event disclosed as required.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value.

Next Steps

• The restricted share units are expected to vest on November 5, 2026, or the date of the 2026 Annual Meeting of Shareholders, whichever is earlier.

Key Dates

Recommendation

This Form 4 filing reports a routine insider equity grant to a director and does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It is an expected disclosure for director compensation.

Keywords

Cardinal Health, CAH, Insider Transaction, Restricted Share Units, RSU Grant, Director Compensation, Equity Award, David C. Evans